{
  "$schema": "folio-library-entry/v1",
  "id": "10665-327942",
  "blocks": [
    {
      "id": "library/10665-327942/blocks/prose-page-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 1",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/page-001.md",
      "narrative": null,
      "content": "EXECUTIVE BOARD \nEB144/CONF./10 \n144th session \n31 January 2019 \nAgenda item 6.1 \n \nPandemic Influenza Preparedness Framework for \nthe sharing of influenza viruses and access to \nvaccines and other benefits \nDraft decision proposed by Secretariat with \namendments by Member States \n \nThe Executive Board, having considered the report contained in document EB144/23 [EU] on \nimplementation of decision WHA71(11) (2018)1 decided to recommend to the Seventy-second World \nHealth Assembly the adoption of the following decision: \nThe Seventy-second World Health Assembly, having considered the report con",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "First page of Executive Board draft decision EB144/CONF./10 (2019) on the Pandemic Influenza Preparedness Framework, showing the Secretariat's text with bracketed amendments from the EU and USA, including requests on genetic sequence data and the Nagoya Protocol.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-327942/blocks/prose-page-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 2",
      "pageStart": 2,
      "pageEnd": 2,
      "target": "../sections/page-002.md",
      "narrative": null,
      "content": "EB144/CONF./10 \n \n \n \n \n \n \n2 \n(c) \nto assess the utility usefulness [EU] of the prototype search engine developed to \nidentify products that potentially [EU] have made use of genetic sequence data of influenza \nviruses with pandemic potential and have not been subject to the benefit-sharing system; \n[EU] \n(d) \nto explore in consultation with Member States [USA] the [EU] possible next steps \nin implementing the principle of acknowledgment of the contributions of data providers \nand active collaboration between raising awareness of the PIP Framework among \ndatabases and initiatives, [EU] data p",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Second page of the PIP Framework draft decision with tracked Member State amendments, covering assessment of a prototype search engine for products using influenza genetic sequence data, acknowledgement of data providers, and an amended footnote in Annex 2 of the Framework.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
